News
Latest
News
FDA seeks feedback on new framework for rare disease drug development
The US agency proposes its new regulatory framework will holistically address the unique challenges of rare disease drug development.
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
NewsFDA approves Roche’s Tecentriq immunotherapy combination for dMMR colon cancer
Authorisation positions monoclonal antibody as a new post-surgery standard of care in stage III deficient mismatch repair colon cancer.
NewsCPHI selects 2026 Pharma Awards winners
Honourees span API development, finished formulation, supply chain, sustainable innovation and leadership excellence.
NewsNobel Prize awarded for optogenetics
The 2026 Nobel Prize in Physiology or Medicine award celebrates a key advancement in neuroscience following breakthrough findings from a 2005 research paper.
NewsBayer invests $2.2bn in new Ohio manufacturing facility
Automated, modular manufacturing site to support growth of firm’s oncology, cardiovascular and renal care portfolio.
More news
News
Teva and Samsung Bioepis expand biosimilar collaboration
Partnership expansion will help strengthen Samsung Bioepis and Teva Pharmaceutical’s global market position and respective pipelines.
News
Exposure rate influences microbial viability risk during pharmaceutical freeze-thaw cycling
Research supports pharmaceutical microbiological risk assessments and thaw-handling steps during manufacture and storage.
News
AstraZeneca commits $2bn to advance ADC combination medicines for cancer
Investment and collaboration agreement with Summit Therapeutics to accelerate next-generation immuno-oncology regimens across multiple tumour types.
News
IMS Solutions launches ‘steroid fingerprint’ diagnostic technology
A new Imperial College London and University of Birmingham spinout is developing mass spectrometry-based tests to improve the diagnosis and stratification of conditions linked to disordered steroid metabolism.
News
Novo secures €1.17bn long-acting injectable deal with Nanexa
Licensing agreement focuses on a delivery technology that provides sustained-release injectable peptides and offers potential to reduce treatment burden in obesity and type 2 diabetes.
News
MHRA approves new combination therapy for small cell lung cancer
Authorisation is based on data showing lurbinectedin plus atezolizumab facilitated a meaningful improvement in survival and progression-free outcomes compared with atezolizumab alone in ES-SCLC.
News
Amgen reports positive topline Phase III Sjögren’s results
Dazodalibep met the primary endpoint in a Phase III study, demonstrating a statistically significant improvement in systemic disease activity in people with moderate-to-severe systemic Sjögren’s disease.
News
Eur. Ph. revises monographs to aid detection of adulterated excipients
The new gas chromatography test strengthens quality control within the pharmaceutical supply chain as well as availability of safe, high-quality medicines, particularly for children.
News
FDA updates drug safety testing rules to embrace non-animal methods
New rule reflects scientific advances where more viable alternatives to animal testing are available, while retaining use of these studies where appropriate.
News
Enhanced microbial cultivation method bridges transition between native habitats and the lab
Applying the continuous-flow technology enabled domestication of previously uncultured bacteria, addressing a key bottleneck in laboratory microbial cultivation.
News
Bayer’s Kerendia approved in US as first new CKD and type 1 diabetes therapy in three decades
FDA’s latest approval authorises Bayer’s non-steroidal mineralocorticoid receptor antagonist (MRA) Kerendia for a third indication.
News
Sanofi trims mature medicines portfolio and divests of three manufacturing sites
Divestment agreement expands decade-long collaboration between Sanofi and Cheplapharm, helps to hone Sanofi’s innovation focus.